Barrett Esophagus-I: Introduction

Barrett's esophagus primarily results from gastroesophageal reflux disease, where a weakened lower esophageal sphincter allows stomach acid to flow back into the esophagus. Prolonged acid exposure damages the esophageal lining, triggering metaplasia—a transformation of the pink mucosal tissue into columnar epithelium similar to intestinal tissue. This adaptive response attempts to protect against further acid damage.

Metaplasia transforms the esophagus's normal stratified squamous epithelium into simple columnar epithelium with goblet-like cells, similar to intestinal tissue. This cellular transformation is the body's defensive mechanism against repeated acid injury. The altered lining becomes more resistant to acid but increases cancer risk, as columnar cells are more prone to dysplastic changes and malignant transformation.

Dysplasia in Barrett's esophagus progresses through distinct stages: non-dysplastic changes represent initial abnormalities, low-grade dysplasia shows mild abnormal cell growth, high-grade dysplasia exhibits severe abnormalities with significant cancer risk, and adenocarcinoma represents actual cancer formation. Each stage indicates increasing cellular abnormality and malignant potential, requiring escalated monitoring and intervention.

Beyond chronic gastroesophageal reflux disease, risk factors include obesity, smoking, alcohol consumption, genetic predisposition, chronic aspirin or anti-inflammatory drug use, and being a white male over 50 years old. These factors either increase acid reflux severity or compromise the esophageal lining's protective mechanisms, elevating Barrett's esophagus development risk.

Upper endoscopy (esophagogastroduodenoscopy) is the primary diagnostic tool, particularly for patients with chronic reflux symptoms and risk factors. If Barrett's esophagus is detected, biopsies assess dysplasia severity. Surveillance schedules depend on findings: no dysplasia requires endoscopy every 3-5 years, low-grade dysplasia every 6-12 months, and high-grade dysplasia demands frequent monitoring or definitive treatment.

High-grade dysplasia requires close monitoring with frequent endoscopies or definitive interventions. Treatment options include radiofrequency ablation, which uses heat to destroy abnormal tissue, or esophagectomy, surgical removal of the affected esophageal segment. These aggressive approaches aim to prevent adenocarcinoma development and are selected based on patient factors and dysplasia extent.

Early detection enables timely intervention before dysplasia progresses to adenocarcinoma, significantly improving outcomes. Regular medical check-ups and lifestyle modifications—including weight management, smoking cessation, and alcohol reduction—minimize complications. Patients with Barrett's esophagus benefit from established surveillance schedules and appropriate management strategies tailored to dysplasia severity.